Table 2.

Prognosis between patients with no statin and statin groups

	No prestroke statins use group (136)	No prestroke statins use group (106)	OR (95% CI)	P*
Death, n (%)	47 (34.6)	23 (21.7)	0.53 (0.29–0.94)	0.029
Major disability, n (%)	54/89 (60.7)	32/83 (38.6)	0.41 (0.22–0.75)	0.004
Major disability+death, n (%)	101 (74.3)	55 (51.9)	0.37 (0.22–0.64)	< 0.001

*Comparison between no pre-stroke statins use group and pre-stroke statins use group. Categorical variables are expressed as frequency (percent) for P values, prognosis was compared between the 2 subgroups by univariate analysis using Pearson χ2 test